# The Efficacy of ESTRATEST® Tablets in Relieving Menopausal Symptoms in Estrogenized, Non-Hysterectomized Postmenopausal Women

> **NCT00141544** · PHASE2 · TERMINATED · sponsor: **Solvay Pharmaceuticals** · enrollment: 28 (actual)

## Conditions studied

- Menopause

## Interventions

- **DRUG:** esterified estrogens 1.25 mg and methyltestosterone 2.5 mg
- **DRUG:** Esterified estrogens 1.25 mg

## Key facts

- **NCT ID:** NCT00141544
- **Lead sponsor:** Solvay Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2004-07
- **Primary completion:** 2007-04
- **Final completion:** 2008-03
- **Target enrollment:** 28 (ACTUAL)
- **Why stopped:** Lack of enrollment
- **Last updated:** 2008-04-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00141544

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00141544, "The Efficacy of ESTRATEST® Tablets in Relieving Menopausal Symptoms in Estrogenized, Non-Hysterectomized Postmenopausal Women". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT00141544. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*